Standing Up to the Opioid Epidemic AACC’s new position statement provides insight on the crucial role clinical laboratories play in combating the opioid crisis. It also shows what measures the healthcare system, Congress, and federal agencies can take to work together on this issue. Learn More
The APO-L1 Testing Debate Evidence has shown that many African Americans carry the Apolipoprotein L1 gene, which contains two variants that cause kidney disease. Emerging data suggests that patients who receive kidneys from donors with this gene have worse outcomes. Learn More
Scientific Impact and the H-Index Expert William E. Schreiber, MD, defines the H-index and its significance in a scientist’s academic achievements. Learn More
Making a Choice We All Can Live With When upgrading automated chemistry and immunochemistry platforms, it’s key to remember that frontline technical staff frequently are more in tune with and are more directly impacted by the shortcomings of current platforms. Learn More
AACC Calls for Pediatric Reference Interval Funding Two dozen professional associations, laboratories, and medical centers have signed on to join AACC in asking Congress for a $10 million increase in the CDC’s Environmental Health Laboratory budget to improve pediatric reference intervals. Learn More
Resolution Bioscience, Janssen Partner on cfDNA Co-Diagnostic for Prostate Cancer In collaboration with Janssen Research & Development, Resolution Bioscience is developing the Resolution HRD liquid biopsy assay as a companion diagnostic for niraparib, a poly ADP ribose polymerase inhibitor that is designed to treat metastatic castration-resistant prostate cancer. Learn More
Practical Approaches to the Diagnosis of Primary Hyperaldosteronism Primary aldosteronism is a group of disorders characterized by inappropriate aldosterone production. Now labeled as a major health concern and the most common cause of hypertension, clinical lab experts face challenges in diagnosing this disorder, where early detection is key. Learn More
FDA Issues Draft Recommendations on Minimizing Biotin Interference With Lab Tests Following a 2017 safety concern that taking high levels of biotin could interfere with lab tests for hormones and cardiac markers, the FDA has issued a new draft guidance that provides recommendations on in vitro diagnostic devices. Learn More
Machine Learning-based Cyst Fluid Analysis Bests Standard-of-Care in Distinguishing Benign, High-risk Pancreatic Cysts A recent study shows evidence that a test that uses machine learning and incorporates data from clinical, molecular, and imaging features of pancreatic cysts outperformed standard-of-care pathology analysis. Learn More